RT Journal Article
SR Electronic
A1 Alexander, Walter
T1 Consolidation with Arsenic Trioxide Significantly Improves Event-free Survival and Overall Survival among Patients with Newly Diagnosed Acute Promyelocytic Leukemia
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 3
SP 12
OP 12
DO 10.1177/155989770700700304
UL http://mdc.sagepub.com/content/7/3/12.1.abstract
AB Arsenic trioxide is an effective and indicated agent for relapsed acute promyelocytic leukemia (APL). A study now demonstrates that arsenic trioxide has clinical benefit for patients with newly diagnosed APL. This article reports findings from the study in which arsenic trioxide was given as consolidation therapy to patients with APL who had complete remission following standard induction therapy.